Development and In vitro Evaluation of Swellable Floating Formulation of Captopril

被引:0
|
作者
Hafiz, Muhammad A. [1 ]
Bashir, Sajid [2 ]
Tariq, Imran [1 ]
Shah, Pervaiz A. [1 ]
Nazar, Hafiz M. I. [1 ]
Amjad, Sohail [1 ]
Latif, Abida [1 ]
Murtaza, Ghulam [3 ]
机构
[1] Univ Punjab, Univ Coll Pharm, Lahore 5400, Pakistan
[2] Univ Sargodha, Fac Pharm, Sargodha, Pakistan
[3] COMSATS Inst Informat Technol, Dept Pharmaceut, Abbottabad, Pakistan
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2014年 / 33卷 / 06期
关键词
Captopril; Direct compression; Floating tablet; HPMC K100M; Psyllium husk; DRUG-DELIVERY SYSTEM; RELEASE; TABLETS; DESIGN; OPTIMIZATION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of the present work was to formulate and evaluate the effervescent floating tablets of captopril using blend of natural and synthetic polymers. Ten formulations of floating tablets were prepared using Psyllium husk, Hydroxypropylmethylcellulose (HPMC K100M) and sodium bicarbonate (NaHCO3) by direct compression technology. Fourier transform infra red spectrometry (FTIR) and Differential scanning calorimetry (DSC) were performed to elucidate the interaction of drug with polymer and excipients. Floating units were evaluated for physicochemical parameters like hardness, diameter, thickness, swelling index, mass uniformity, percent drug content, buoyancy lag time and drug release. Swelling and in vitro release studies were carried out in 0.1 N HCl at 37 degrees C using paddle apparatus. The formulated tablets were optimized on the basis of buoyancy time and drug release. FTIR and DSC results showed no detectable incompatibility between drug and polymers. The diameter of all formulations was found to be in the range of 9.82-10.78 mm; thickness was in the range of 3.914-4.437 mm. The hardness was calculated to be in the range of 1.92-2.75 kg/cm(2). The buoyancy time remained less than 3.5 min and duration of floating did not exceed 12 h for all formulations. The results of swelling studies showed higher percent swelling on increasing the polymer concentration. The value of 'n' was in the range of 0.409-0.755 which is indicator of drug release by fickian as well as non-fickian or anomalous diffusion mechanisms. The study concluded, C4 as the best optimized formulation for the extent of drug release was found to be around 99.24 +/- 1.26% and showed buoyancy lag time at 114 +/- 10 s with floating duration of >= 12 h.
引用
收藏
页码:1001 / 1008
页数:8
相关论文
共 50 条
  • [1] Formulation and Evaluation of Swellable and Floating Gastroretentive Ciprofloxacin Hydrochloride Tablets
    Arza, Ramji Anil Kumar
    Gonugunta, Chandra Sekhara Rao
    Veerareddy, Prabhakar Reddy
    AAPS PHARMSCITECH, 2009, 10 (01): : 220 - 226
  • [2] Formulation and Evaluation of Swellable and Floating Gastroretentive Ciprofloxacin Hydrochloride Tablets
    Ramji Anil Kumar Arza
    Chandra Sekhara Rao Gonugunta
    Prabhakar Reddy Veerareddy
    AAPS PharmSciTech, 2009, 10 : 220 - 226
  • [3] FORMULATION AND EVALUATION OF BILAYER FLOATING TABLETS OF ATORVASTATIN AND CAPTOPRIL
    Hari, Kuralla
    Bhavani, Chitti
    Rajeswari, Pullabhatla
    Rajeswari, Saripilli
    Vasavi, Gokavarapu
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (09): : 4676 - 4690
  • [4] Formulation Development, Optimization and Characterization of Floating Beads of Captopril
    Thadkala, Kiran
    Kumari, N. P. Prema
    Prathyusha, R.
    Raju, Anju
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2013, 2 (02): : 32 - 46
  • [5] Formulation and Development of Floating Capsules of Celecoxib: In Vitro and In Vivo Evaluation
    Ali, Javed
    Arora, Shweta
    Ahuja, Alka
    Babbar, Anil K.
    Sharma, Rakesh K.
    Khar, Roop K.
    AAPS PHARMSCITECH, 2007, 8 (04):
  • [6] Formulation and development of floating capsules of celecoxib: In vitro and in vivo evaluation
    Ali J.
    Arora S.
    Ahuja A.
    Babbar A.K.
    Sharma R.K.
    Khar R.K.
    AAPS PharmSciTech, 8 (4) : E1 - E8
  • [7] Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers
    Teaima, Mahmoud
    Hamid, Magdi M. Abdel
    Shoman, Nabil A.
    Jasti, Bhaskara R.
    El-Nabarawi, Mohamed A.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2741 - 2757
  • [8] Formulation and Evaluation of Gastric Oral Floating Capsules Containing Captopril
    Mangilal, Teelavath
    Patnaik, K. S. K. Rao
    Thadkala, Kiran
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2014, 3 (03): : 17 - 28
  • [9] Formulation Optimization and In-vitro Evaluation of Oral Floating Captopril Matrix Tablets using Factorial Design
    Ahsan, Muhammad
    Abbas, Nasir
    Hussain, Amjad
    Saeed, Hamid
    Shah, Pervaiz Akhtar
    Mohammad, Sohail
    Arshad, Muhammad Sohail
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (10) : 1737 - 1748
  • [10] Formulation Development and In-vitro Evaluation of Floating Tablets of Ciprofloxacin HCl
    Venkateswarlu, Kambham
    Preethi, Jami Komala
    Kiran, Badithala Siva Sai
    ASIAN JOURNAL OF PHARMACEUTICS, 2016, 10 (04) : 271 - 278